• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 3. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azepanes Azepanes
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azepanes

Comprehensive Overview of 3-azabicyclo[3.2.1]octane-8-methanol hydrochloride (CAS No. 920016-99-5)

The compound 3-azabicyclo[3.2.1]octane-8-methanol hydrochloride (CAS No. 920016-99-5) is a bicyclic organic molecule featuring a unique structural framework that combines an azabicyclo core with a hydroxymethyl functional group. This molecular architecture makes it a valuable intermediate in pharmaceutical research, particularly in the development of central nervous system (CNS) therapeutics and enzyme inhibitors. The hydrochloride salt form enhances its solubility and stability, which is critical for formulation and bioavailability studies.

In recent years, the demand for 3-azabicyclo[3.2.1]octane derivatives has surged due to their potential applications in neurological disorders and pain management. Researchers are particularly interested in its role as a scaffold for designing G protein-coupled receptor (GPCR) modulators, a hot topic in drug discovery. The compound's rigid bicyclic structure offers conformational constraints that can improve target selectivity, a key consideration in modern precision medicine.

From a synthetic chemistry perspective, CAS No. 920016-99-5 is often discussed in the context of asymmetric synthesis and chiral resolution techniques. Its stereochemistry is crucial for biological activity, aligning with the growing emphasis on enantiopure drugs in the pharmaceutical industry. Analytical methods such as HPLC and NMR spectroscopy are routinely employed to characterize this compound, addressing the need for rigorous quality control in API manufacturing.

The compound's hydrophilic-lipophilic balance (HLB) makes it a candidate for drug delivery systems, especially in crossing the blood-brain barrier (BBB)—a frequent search topic among neuroscientists. Recent publications have explored its derivatization for neuroprotective agents, coinciding with rising global interest in neurodegenerative disease research like Alzheimer's and Parkinson's.

Environmental and regulatory aspects of 3-azabicyclo[3.2.1]octane-8-methanol hydrochloride are also noteworthy. Its green chemistry profile is being evaluated through atom economy assessments and biodegradability studies, reflecting the industry's shift toward sustainable pharmaceutical synthesis. These dimensions are increasingly captured in ESG (Environmental, Social, and Governance) metrics for chemical suppliers.

In computational chemistry, this compound serves as a test case for molecular docking simulations due to its bridged ring system, which presents unique challenges for force field parameterization. Such applications resonate with the expanding use of AI-driven drug design tools, a trending search term in scientific circles.

Market analysts highlight the growing patent landscape around azabicyclo compounds, with 920016-99-5 appearing in several IP filings for ion channel modulators. This aligns with commercial interest in personalized medicine approaches, where tailored therapeutics require specialized chemical building blocks.

For formulation scientists, the hygroscopicity of the hydrochloride salt form necessitates careful excipient selection, tying into broader discussions about solid-state chemistry and polymorphism control—subjects frequently queried in pharmaceutical forums.

In summary, 3-azabicyclo[3.2.1]octane-8-methanol hydrochloride represents a multifaceted compound bridging medicinal chemistry, process optimization, and therapeutic innovation. Its continued study addresses both fundamental scientific questions and applied industrial needs, making it a compound of enduring relevance across multiple disciplines.

• 51153-70-9(1H-Cyclopenta[c]pyridine-6-methanol,octahydro-,(4a-alpha-,6-alpha-,7a-alpha-)-(9CI))
• 128315-96-8(3-Azabicyclo[3.3.1]nonan-7-ylmethanol)
• 144539-77-5([(3S)-piperidin-3-yl]methanol)
• 848070-01-9(5-(hydroxymethyl)piperidin-3-ylmethanol)
• 37675-20-0([(3R)-piperidin-3-yl]methanol)
• 73579-06-3(3-Piperidine ethanol)
• 6457-49-4(piperidin-4-ylmethanol)
• 4606-65-9(piperidin-3-ylmethanol)
• 51071-76-2(1H-Cyclopenta[c]pyridine-6-methanol,octahydro-,(4a-alpha-,6-bta-,7a-alpha-)-(9CI))
• 89151-39-3(2-(Piperidin-4-yl)propan-1-ol)